Amaç: Günümüzde nötrofil/lenfosit oranı, platelet/lenfosit oranı ve CA 19-9 gibi birçok preoperatif proinflamatuar belirteç çeşitli kanser türlerinin prognozunun tahmininde anlamlı olduklarını bildirmişlerdir. Bu çalışmada amacımız pankreatik duktal adenokarsinom (PDAK) nedeniyle opere edilen hastalarda bu preoperatif parametrelerin değerini araştırmaktır. Materyaller ve Metodlar: Eylül 2011 ile Eylül 2016 tarihleri arasında PDAK nedeniyle opere edilen 118 hastaya ait veriler retrospektif olarak incelendi. Preoperatif dönemde tüm hastaların tam kan sayımlarında; beyaz küre, hemoglobin düzeyi, mutlak nötrofil ve lenfosit sayısı, platelet sayısı, nötrofil/lenfosit oranı (NLO), platelet/lenfosit oranı (PLO) ve CA19-9 düzeyleri kayıt edildi. Ay...
Background/Aims: The aim of the study is to assess the prognostic value of pretreatment lymphocyte, ...
Background/Aims: We investigated whether inflammatory markers such as neutrophil-lymphocyte ratio (N...
Background: For prognostic evaluation of pancreatic ductal adenocarcinoma (PDAC), the only well-esta...
Background: Pancreatic adenocarcinoma has a high mortality rate. A prognostic tool is essential for ...
As a poor prognosis indicator in patients with pancreatic ductal adenocarcinoma (PDCA), lymph node (...
AbstractBackground and aims. Recognized prognostic factors for resected pancreatic ductal adenocarci...
Introduction: Tumor and systemic inflammatory markers predict survival. This retrospective study aim...
A grant from the One-University Open Access Fund at the University of Kansas was used to defray the ...
Introduction.Difficulties in advanced pancreatic ductal adenocarcinoma (PDAC) treatment require a co...
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) current...
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer often diagnosed late. Earlier detection i...
BACKGROUND:Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) current...
The prognosis in patients with pancreatic cancer is poor and some authors describe it as a lethal di...
Abstract Background Carbohydrate antigen (CA) 19‐9 and histological grade can serve as indicators of...
Recently, the preoperative platelet to lymphocyte ratio (PLR) has been found reported to predict onc...
Background/Aims: The aim of the study is to assess the prognostic value of pretreatment lymphocyte, ...
Background/Aims: We investigated whether inflammatory markers such as neutrophil-lymphocyte ratio (N...
Background: For prognostic evaluation of pancreatic ductal adenocarcinoma (PDAC), the only well-esta...
Background: Pancreatic adenocarcinoma has a high mortality rate. A prognostic tool is essential for ...
As a poor prognosis indicator in patients with pancreatic ductal adenocarcinoma (PDCA), lymph node (...
AbstractBackground and aims. Recognized prognostic factors for resected pancreatic ductal adenocarci...
Introduction: Tumor and systemic inflammatory markers predict survival. This retrospective study aim...
A grant from the One-University Open Access Fund at the University of Kansas was used to defray the ...
Introduction.Difficulties in advanced pancreatic ductal adenocarcinoma (PDAC) treatment require a co...
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) current...
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer often diagnosed late. Earlier detection i...
BACKGROUND:Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) current...
The prognosis in patients with pancreatic cancer is poor and some authors describe it as a lethal di...
Abstract Background Carbohydrate antigen (CA) 19‐9 and histological grade can serve as indicators of...
Recently, the preoperative platelet to lymphocyte ratio (PLR) has been found reported to predict onc...
Background/Aims: The aim of the study is to assess the prognostic value of pretreatment lymphocyte, ...
Background/Aims: We investigated whether inflammatory markers such as neutrophil-lymphocyte ratio (N...
Background: For prognostic evaluation of pancreatic ductal adenocarcinoma (PDAC), the only well-esta...